Global Infectious Disease Treatment Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Disease Type;

Viral Diseases, Bacterial Diseases, Fungal Diseases, Parasitic Diseases, and Others.

By Treatment;

Antibiotics, Antivirals, Antifungals, Anti-Parasitic, and Others.

By End User;

Hospitals & Clinics, Ambulatory Care Centers, and others.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa, and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn216877097 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global Infectious Disease Treatment Market (USD Million), 2021 - 2031

In the year 2024, the Global Infectious Disease Treatment Market was valued at USD 129,468.12 million. The size of this market is expected to increase to USD 235,157.05 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 8.9%.

The rising prevalence of infectious diseases, coupled with increasing expenditure to enhance the penetration rate of treatments, is significantly driving the growth of the Global Infectious Disease Treatment Market. Initiatives aimed at raising awareness about the diagnosis and treatment of these conditions, alongside a surge in clinical trials for new drug development, are also key factors contributing to market expansion. The market is expected to witness numerous patent expirations of branded drugs during the forecast period, leading to the availability of cost-effective generic alternatives. These generics, which possess the same drug composition as their branded counterparts, are often preferred by physicians for their affordability. Additionally, a favorable reimbursement landscape covering the diagnosis and treatment of infectious diseases is likely to further propel market growth. Key industry players are actively developing new products and receiving approvals for commercialization. For instance, in December 2022, Gilead Sciences received FDA approval for Sunlenca, a treatment for HIV-1 infection in adults with multi-drug resistant HIV-1.

Despite these positive trends, several challenges could impede market growth. A lack of awareness about infectious diseases and their treatments, coupled with low treatment adoption rates, particularly in regions like Africa and Asia, where the incidence of infectious disorders is high, may hinder market expansion. These regions often suffer from a low penetration rate of effective treatments, underscoring the need for increased educational and healthcare infrastructure efforts to improve disease management and treatment accessibility.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Disease Type
    2. Market Snapshot, By Treatment
    3. Market Snapshot, By End User
    4. Market Snapshot, By Region
  4. Global Infectious Disease Treatment Market
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Rising incidence of infectious diseases
        2. Growing awareness and diagnosis rates
      2. Restraints
        1. High cost of drug development
        2. Drug resistance
      3. Opportunities
        1. Focus on preventive treatments
        2. Personalized medicine
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry

  5. Market Segmentation
    1. Global Infectious Disease Treatment Market, By Disease Type, 2023 - 2033 (USD Million)
      1. Viral Diseases
      2. Bacterial Diseases
      3. Fungal Diseases
      4. Parasitic Diseases
      5. Others
    2. Global Infectious Disease Treatment Market, By Treatment, 2021 - 2031 (USD Million)
      1. Antibiotics
      2. Antivirals
      3. Antifungals
      4. Anti-Parasitic
      5. Others
    3. Global Infectious Disease Treatment Market, By End User, 2021 - 2031 (USD Million)
      1. Hospitals and Clinics
      2. Ambulatory Care Centers
      3. Others
    4. Global Infectious Disease Treatment Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. F. Hoffmann-La Roche Ltd
      2. Pfizer Inc
      3. Janssen Global Services, LLC
      4. Sanofi
  7. Analyst Views
  8. Future Outlook of the Market